MY128351A - ß2-ADRENERGIC RECEPTOR AGONISTS - Google Patents
ß2-ADRENERGIC RECEPTOR AGONISTSInfo
- Publication number
- MY128351A MY128351A MYPI9902273A MY128351A MY 128351 A MY128351 A MY 128351A MY PI9902273 A MYPI9902273 A MY PI9902273A MY 128351 A MY128351 A MY 128351A
- Authority
- MY
- Malaysia
- Prior art keywords
- receptor agonists
- adrenergic receptor
- useful
- treatment
- bronchitis
- Prior art date
Links
- 239000000048 adrenergic agonist Substances 0.000 title abstract 2
- 229940126157 adrenergic receptor agonist Drugs 0.000 title abstract 2
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 title abstract 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 title abstract 2
- 208000001738 Nervous System Trauma Diseases 0.000 abstract 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 abstract 1
- 206010036600 Premature labour Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000028412 nervous system injury Diseases 0.000 abstract 1
- 208000026440 premature labor Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
DISCLOSED ARE MULTIBINDING COMPOUNDS WHICH ARE β2 ADRENERGIC RECEPTOR AGONISTS AND ARE USEFUL IN THE TREATMENT AND PREVENTION OF RESPIRATORY DISEASES SUCH AS ASTHMA. BRONCHITIS.THEY ARE ALSO USEFUL IN THE TREATMENT OF NERVOUS SYSTEM INJURY AND PREMATURE LABOR.MOST ILLUSTRATIVE DRAWING : (FIGURE 1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI9902273 MY128351A (en) | 1999-06-07 | 1999-06-07 | ß2-ADRENERGIC RECEPTOR AGONISTS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI9902273 MY128351A (en) | 1999-06-07 | 1999-06-07 | ß2-ADRENERGIC RECEPTOR AGONISTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY128351A true MY128351A (en) | 2007-01-31 |
Family
ID=47278600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI9902273 MY128351A (en) | 1999-06-07 | 1999-06-07 | ß2-ADRENERGIC RECEPTOR AGONISTS |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY128351A (en) |
-
1999
- 1999-06-07 MY MYPI9902273 patent/MY128351A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1869A (en) | b2- Adrenergic receptor agonists. | |
| IL149317A0 (en) | β2-ADRENERGIC RECEPTOR AGONISTS | |
| YU42302A (en) | Beta2-adrenergic receptor agonists | |
| BG106762A (en) | Polycycloalkylpurines as adenosine receptor antagonists | |
| WO2003057698A3 (en) | Spiroazacyclic compounds as monoamine receptor modulators | |
| HUP0600780A2 (en) | Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies | |
| NZ329627A (en) | 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones | |
| NZ522326A (en) | Adenosine A2A receptor antagonists | |
| IL162616A0 (en) | Tetrahydroquinoline analogues as muscarinic agonists | |
| NZ332780A (en) | Substituted amines for the treatment of neurological and neuropsychiatric disorders | |
| EP0835869A3 (en) | New serotonin 5-HT1F agonists | |
| WO2004009559A3 (en) | Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents | |
| IL141957A0 (en) | 5ht1 receptor agonists and metoclopramide for the treatment of migraine | |
| BG105270A (en) | Tetrahydropyridoethers | |
| HU9700109D0 (en) | Triazole compounds and their use as dopamine-d3-ligands | |
| WO1999047131A3 (en) | Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor | |
| CA2378613A1 (en) | Selective iglur5 receptor antagonists for the treatment of migraine | |
| TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
| ZA200003768B (en) | Methods and compositions for treating diseases and conditions of the eye. | |
| HK1046404A1 (en) | Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists | |
| MXPA02000680A (en) | Vgf polypeptides and methods of treating vgf-related disorders. | |
| WO2003072572A8 (en) | Beta3-adrenergic receptor agonists | |
| MXPA02001204A (en) | Calcilytic compounds. | |
| IL135634A0 (en) | 5-htif agonists | |
| MY128351A (en) | ß2-ADRENERGIC RECEPTOR AGONISTS |